118 related articles for article (PubMed ID: 9894716)
21. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
[TBL] [Abstract][Full Text] [Related]
22. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
23. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
24. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
25. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.
Heldal D; Tjønnfjord G; Brinch L; Albrechtsen D; Egeland T; Steen R; Solheim BG; Evensen SA
Bone Marrow Transplant; 2000 Jun; 25(11):1129-36. PubMed ID: 10849524
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic transplantation of peripheral blood progenitor cells in children: experience of two pediatric centers.
Miniero R; Busca A; Bonetti F; Giorgiani G; Zecca M; Berger M; Incarbone E; Vassallo E; Perotti C; Locatelli F
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S33-6. PubMed ID: 9989887
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic peripheral blood stem cell transplantation (PBSCT) from HLA-identical sibling donors in children with hematological diseases: a single center pilot study.
Benito AI; Gonzalez-Vicent M; Garcia F; Balas A; Quintero V; Madero L; Vicario JL; Diaz MA
Bone Marrow Transplant; 2001 Sep; 28(6):537-43. PubMed ID: 11607765
[TBL] [Abstract][Full Text] [Related]
28. Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study.
Heldal D; Brinch L; Tjønnfjord G; Solheim BG; Egeland T; Albrechtsen D; Aamodt G; Evensen SA
Bone Marrow Transplant; 2003 Aug; 32(3):257-64. PubMed ID: 12858196
[TBL] [Abstract][Full Text] [Related]
29. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
30. One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
Mengarelli A; Iori AP; Romano A; Cerretti R; Cerilli L; De Propris MS; Fenu S; Moleti ML; De Felice L; Girelli G; Arcese W
Haematologica; 2003 Mar; 88(3):315-23. PubMed ID: 12651271
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
[TBL] [Abstract][Full Text] [Related]
32. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.
Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS
Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japan.
Koga Y; Nagatoshi Y; Kawano Y; Okamura J
Bone Marrow Transplant; 2003 Jul; 32(2):171-6. PubMed ID: 12838282
[TBL] [Abstract][Full Text] [Related]
34. Pilot study of allogeneic G-CSF-stimulated bone marrow transplantation: harvest, engraftment, and graft-versus-host disease.
Ostronoff M; Ostronoff F; Souto Maior P; Matias C; Calixto R; Sucupira A; Domingues M; Florencio R; Tagliari C
Biol Blood Marrow Transplant; 2006 Jul; 12(7):729-33. PubMed ID: 16785062
[TBL] [Abstract][Full Text] [Related]
35. Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective.
Couban S; Dranitsaris G; Andreou P; Price S; Tinker L; Foley R; Walker IR; Jamal S; Jamal N; Spaner D; Lipton J; Meharchand J; Messner HA
Bone Marrow Transplant; 1998 Dec; 22(12):1199-205. PubMed ID: 9894724
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic peripheral blood stem cell transplantation in 23 adult patients with hematologic malignancies: a single-center experience.
Takenaka K; Shinagawa K; Sunami K; Fujii N; Hiramatsu Y; Maeda Y; Nawa Y; Katayama Y; Teshima T; Ishimaru F; Kiura K; Ikeda K; Harada M
Int J Hematol; 2000 Oct; 72(3):362-70. PubMed ID: 11185996
[TBL] [Abstract][Full Text] [Related]
38. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
39. Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies.
Rabitsch W; Reiter E; Keil F; Malzer R; Leitner G; Fischer G; Dieckman K; Kalhs P; Lechner K; Greinix HT
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S49-52. PubMed ID: 9916635
[TBL] [Abstract][Full Text] [Related]
40. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]